CLINICAL AND LABORATORY FEATURES OF THE COURSE VIRAL HEPATITIS A IN PATIENTS OVER 50
- Authors: Naidenko A.1
-
Affiliations:
- Voronezh State Medical University
- Issue: Vol 11 (2022): Materials of the XVIII International Burdenkov Scientific Conference on April 14-16, 2022
- Pages: 208-210
- Section: Инфекционные болезни и иммунология
- URL: https://new.vestnik-surgery.com/index.php/2415-7805/article/view/7287
Cite item
Full Text
Abstract
Viral hepatitis A (HAV) still remains an urgent public health problem. In this study, we analyze the clinical and laboratory features of the course of HAV in patients older than 50 years in Voronezh and the Voronezh region for the period from 2018 to 2021. Under observation were 31 patients diagnosed with acute HAV, icteric form. The mean age of the patients was 54.3±4.2 years. The diagnosis was established on the basis of clinical and laboratory studies in accordance with the International Classification of Diseases of the tenth revision. The diagnosis was confirmed by enzyme immunoassay by detecting antibodies to the HA virus aHAV IgM in the blood. In most patients, the course of the disease was moderate. Most patients had a preicteric period according to the dyspeptic variant with an increase in body temperature. Such a diagnostic criterion for the classical course of HAV, as an improvement in well-being with the onset of jaundice, was observed in 1/3 of patients. Most of the patients were admitted to the hospital with a diagnosis of hepatitis, unspecified. On examination, hepatomegaly was detected in 93.5% of patients. In the general blood test, half of the patients had normocytosis. Cytolysis indices averaged 15 norms. Biochemical indicators of cholestasis were also higher than normal in 100% of patients.
Keywords
Full Text
Relevance. HAV is an acute, cyclic, benign disease that is common among children. According to WHO experts, up to 1.4 million people are infected with HAV annually in the world [1]. The Russian Federation belongs to the countries with medium HAV endemicity. The maintenance of the epidemiological process is carried out through the implementation of the contact-household route of transmission of the pathogen, in case of non-compliance with the rules of personal hygiene [2, 3, 6]. According to the official data of Rospotrebnadzor in the Voronezh region, over the past 10 years, there has been a decrease in the incidence of HAV from 6.20 to 3.37 per 100,000 population. There is also a tendency to reduce the number of sick children from 0 to 17 years old from 22.9% to 11.4% [3, 7]. A decrease in HAV circulation among children leads to an increase in the cohort of adults who do not have immunity to the virus and, as a result, the number of clinically pronounced forms [4, 5].
Objective. To study the clinical and laboratory course of HAV in patients older than 50 years at the present stage.
Materials and methods. Under observation were 31 patients (20 men and 11 women) with a diagnosis of CAA, icteric form, aged 50-66 years, who were treated at the Voronezh VOKIB in 2018-2021. The diagnosis was established on the basis of clinical and laboratory studies in accordance with the International Classification of Diseases of the tenth revision. The diagnosis was confirmed by enzyme immunoassay by detecting antibodies to the HA virus aHAV IgM in the blood.
The results obtained were subjected to statistical processing using non-parametric tests Mann - Whitney, Kruskal - Wallis using the computer program SPSS Statistics 19.0.
Results. Patients were sent for hospitalization on the 8.3±3.5 day from the onset of the disease.
The duration of the preicteric period was 5.2±2.9 days. In the preicteric period, 90.3% of patients had asthenovegetative symptoms, dyspeptic disorders in 93.5%, fever in 93.5%, catarrhal symptoms in 12.9% of patients. Improvement in well-being with the appearance of jaundice was noted by 35.5% of patients.
The diagnosis with which patients were admitted to the hospital was different: 54.8% of patients had hepatitis unspecified, 6.4% had a respiratory infection, and 3.2% had chronic hepatitis C. Only 9.7% of patients, in who had a history of established contact with a patient with CAV, the diagnosis of the referring institution was CAV. 70.9% of patients were residents of Voronezh, 29.1% of patients lived in the Voronezh region (Kantemirovsky, Petropavlovsky, Ostrogozhsky, Semiluksky districts).
All patients had comorbid somatic diseases. Thus, 77.4% of patients had chronic diseases of the gastrointestinal tract, 22.6% of patients had damage to the cardiovascular system, 9.7% had liver cysts, and 3.2% had liver cirrhosis.
On examination, icterus of the sclera and yellowness of the skin were detected in 97.6% of patients, hepatomegaly was observed in 93.5% of patients, and splenomegaly in 16.1%. 16.1% of patients complained of pruritus.
In the general blood test, lymphocytosis was detected in 38.7% of patients, leukocytosis in 9.7%, and normocytosis in the rest of the patients. In the biochemical analysis of blood, there was an increase in total bilirubin to 115±69.2 µmol/l, direct bilirubin 74.1±48.2 µmol/l, ALT 632.4±434.7 IU/l, thymol test - 22.1 ±9.2 units, alkaline phosphatase 579.9±263.7 IU/l, gamma-glutamate transpeptidase - 360.2±153.2 units/l.
The average duration of hospitalization was 16.3±6.4 days. Patients were prescribed basic pathogenetic, symptomatic treatment, including a sparing motor regimen and diet, plenty of fluids, and vitamin therapy.
Discussion. According to the results of the study of the characteristics of the course of HAV in patients older than 50 years, the course was observed predominantly according to the asthenovegetative and dyspeptic variant. Every third patient experienced an improvement in well-being with the appearance of jaundice. All patients had concomitant pathologies, among which diseases of the gastrointestinal tract prevailed. Laboratory diagnostics showed an increase in the following biochemical parameters: total bilirubin, direct bilirubin, ALT, thymol test, alkaline phosphatase, gamma-glutamate transpeptidase.
Conclusion.
1. Over the past 10 years in Voronezh and the Voronezh region there has been a marked decrease in the incidence of HAV.
2. Improving the sanitary and hygienic living conditions of the population has led to a decrease in the circulation of the HA virus among children and, as a result, an increase in the number of non-immune adults.
3. Due to the relative well-being in the region for this disease, clinicians are less alert to HAV. Faced with patients in the prodromal period, with a polymorphism of clinical manifestations, primary care physicians have difficulties in the diagnostic search, leading to late diagnosis, as a result of this untimely hospitalization.
About the authors
Anastasia Naidenko
Voronezh State Medical University
Author for correspondence.
Email: ledianastasianaidenko@yandex.ru
ORCID iD: 0000-0001-6818-6532
SPIN-code: 7762-6670
Student
Russian Federation, Russia, Voronezh, Studencheskaya street, 10References
- WHO: Hepatitis A. fact sheet No 328. Updated July 2021. Available at: /www.who.int/ru/news-room/fact-sheets/detail/hepatitis-a.
- Чуланов В.П., Пименов Н.Н., Карандашова И.В. и др. Современные особенности эпидемического процесса гепатита А в России и странах Европы, определяющие стратегии его профилактики // Эпидемиология и инфекционные болезни. – 2012. – №3. – С. 28-34.
- Доклад «О состоянии санитарно-эпидемиологического благополучия населения в
- Воронежской области в 2020 году» – Воронеж: Управление Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека по Воронежской области, 2021 –193 с.
- Калинина Э.В., Емельянова А.Н., Чупрова Г.А. и др. Вирусный гепатит А: особенности клинического течения у взрослых // Сибирский медицинский журнал. – 2017. - № 2. С. 39-41.
- Чуланов В.П. и др., Клиническое значение генетического разнообразия вируса гепатита А // Эпидемиология и инфекционные болезни. – 2014. – T. 19, №4. – C. 12-17.
- Болотских В.И., Притулина Ю.Г., Пегусов С.М. и др. Инфекционные болезни: учебное пособие / В.И. Болотских, Ю.Г. Притулина, С.М Пегусов и др. – Воронеж: Издательско-полиграфический центр "Научная книга", 2018. – С. 282.
- Федеральные клинические рекомендации «Острый вирусный гепатит А» Москва, 2019 г.


